Evidence map›Paper›PMID 36134160›Full record

ArticleNanoscale advances2021

Biogenic selenium nanoparticles produced by

Katerina Spyridopoulou, Eleni Tryfonopoulou, Georgios Aindelis, Petros Ypsilantis, Charalampos Sarafidis, Orestis Kalogirou, Katerina Chlichlia

Abstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. BioMed research international · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Screening, characterization, and potential anti-hangover ability of selenium nanoparticle-enriched lactobacillus.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Periodic Table of Immunomodulatory Elements and Derived Two-Dimensional Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Frontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katerina SpyridopoulouDepartment of Molecular Biology and Genetics, Democritus University of Thrace University Campus Dragana 68100 Alexandroupolis Greece achlichl@mbg.duth.gr.ORCID https://orcid.org/0000-0003-4905-9567
Eleni TryfonopoulouDepartment of Molecular Biology and Genetics, Democritus University of Thrace University Campus Dragana 68100 Alexandroupolis Greece achlichl@mbg.duth.gr.
Georgios AindelisDepartment of Molecular Biology and Genetics, Democritus University of Thrace University Campus Dragana 68100 Alexandroupolis Greece achlichl@mbg.duth.gr.
Petros YpsilantisLaboratory of Experimental Surgery and Surgical Research, Department of Medicine, Democritus University of Thrace 68100 Alexandroupolis Greece.
Charalampos SarafidisDepartment of Physics, Aristotle University of Thessaloniki 54124 Thessaloniki Greece.ORCID https://orcid.org/0000-0002-5990-0973
Orestis KalogirouDepartment of Physics, Aristotle University of Thessaloniki 54124 Thessaloniki Greece.
Katerina ChlichliaDepartment of Molecular Biology and Genetics, Democritus University of Thrace University Campus Dragana 68100 Alexandroupolis Greece achlichl@mbg.duth.gr.ORCID https://orcid.org/0000-0003-4952-0675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium compounds exhibit excellent anticancer properties but have a narrow therapeutic window. Selenium nanoparticles, however, are less toxic compared to other selenium forms, and their biogenic production leads to improved bioavailability. Herein, we used the probiotic strain

Identifiers

PMID36134160
PMCPMC9417964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.